Circulating Tumor Cell (CTC) Diagnostics Market
Biotechnology

Circulating Tumor Cell (CTC) Diagnostics Market is estimated to grow at a CAGR of 9.7% by 2028.

Circulating tumor cells are the seeds for growth and metastases for additional tumors in distant organs and is responsible for majority of cancer related deaths. The diagnosis, detection and analysis of CTC can assist in patients’ prognoses determine appropriate tailored treatments for the patients. The CTC diagnosis has a lot of advantages for traditional diagnostic procedures.

Thermo Fischer Scientific, Inc. and QIAGEN – Notable Market Players in Circulating Tumor Cell (CTC) Diagnostics Market

The Circulating Tumor Cell (CTC) Diagnostics market majorly consists of the players such as Thermo Fisher Scientific, StemCell Technologies, Inc, QIAGEN, Precision Medicine Group, LLC, Advanced Cell Diagnostics (Bio-Techne Corporation), Epic Lifesciences, Screencell, Ikonisys, Inc, IVDiagnostics, Fluxion Biosciences among others.

The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have adopted several inorganic and organic strategies to accelerate their growth and improve their market position.

Below is the list of the growth strategies done by the players operating in the Circulating Tumor Cell (CTC) Diagnostics ssMarket:

Year News
Dec-2021 Epic Sciences, Inc. announced the launch of DefineMBC, a novel metastatic breast cancer (MBC) test that includes both cell-based and cell-free analysis from a single blood draw. DefineMBC provides comprehensive MBC profiling when a tissue biopsy result is not available.
July-2021 QIAGEN announced a global strategic alliance with Japan’s Sysmex Corporation for the development and commercialization of cancer companion diagnostics. The alliance aimed to foster collaborations with pharmaceutical companies for the development of drug treatments for cancer and promote early clinical adoption of ultra-sensitive liquid biopsy companion diagnostics.
Apr-2021 Thermo Fisher Scientific Inc announced the launch of the Thermo Scientific KingFisher Apex Purification System, a high-throughput sample purification instrument designed for scientists who need to automate the extraction of DNA, RNA, proteins and cells from an array of sample types samples such as circulating tumor cells, T-cells and exosomes.